FYI, they are not focused on growing bud. They are cultivating genetically stable pesticide free clones, with full "seed-to-sale" tracking on each one...
LiveWire Ergogenics, Inc. (OTC: LVVV), a company focused on research partnerships, product development and commercialization of cannabinoid-based products, continues its push into the medical and recreational marijuana business to become the premier supplier for genetics cloning. The company announced today that agreements have been made with a group of private investors to provide funding and equipment lease financing for future projects. Additionally, Bill Hodson, CEO of LiveWire, has been appointed to the action committee for the Inland Empire chapter of NORML, the National Organization to Reform Marijuana Laws.
News 
Market Data 
Discover 
